Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jean A. Hosutt"'
Autor:
Jean A. Hosutt, Edward M. Stricker
Publikováno v:
Physiology & Behavior. 27:463-468
Administration of the α-adrenergic receptor blocker phentolamine is known to lower arterial blood pressure and to increase renin secretion and water intake in rats. In the present experiments, drinking by rats after subcutaneous administration of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2265351ecdc00fa0b814f66a7bee3dcf
https://doi.org/10.1016/0031-9384(81)90332-2
https://doi.org/10.1016/0031-9384(81)90332-2
Publikováno v:
Physiology & Behavior. 23:605-607
Rats infused intravenously with homologous renin (0.1–16 U) for 40 min exhibited a linear relation between administered dose and water intake. At the lower doses, observed plasma renin activities also were proportional to water consumption but the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f84afbd96451e9826246fc62915930a
https://doi.org/10.1016/0031-9384(79)90065-9
https://doi.org/10.1016/0031-9384(79)90065-9
Publikováno v:
Physiologybehavior. 21(4)
Drinking induced in rats by systemic isoproterenol treatment is markedly attenuated after bilateral nephrectomy. The present experiments demonstrate that the hypotension produced by iso-proterenol treatment was more profound, and lasted much longer,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c157a5eb7f4edbefc192f580d8c0935
https://pubmed.ncbi.nlm.nih.gov/740778
https://pubmed.ncbi.nlm.nih.gov/740778
Publikováno v:
Journal of comparative and physiological psychology. 95(1)
electrolytic lesions of the subfornical organ (SFO) in rats are known to abolish their drinking response to intravenous infusion of angiotensin II (AII). Such lesions also attenuate drinking after 20% polyethylene glycol solution (PEG) is given subcu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8237ddbf04945978c23de49f0ad7dfea
https://pubmed.ncbi.nlm.nih.gov/7217405
https://pubmed.ncbi.nlm.nih.gov/7217405
Publikováno v:
Clinical Research Practices and Drug Regulatory Affairs. 3:439-439
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c07faf726ab30424ac42a29cb712966
https://doi.org/10.3109/10601338509051074
https://doi.org/10.3109/10601338509051074
Publikováno v:
Controlled Clinical Trials. 7:251
of patients were evaluable. Primary reasons for non-evaluability in therapeutic protocols included insufficient evidence of infection (28%), resistant organisms (3), insufficient course of therapy (2$), and underlying disease or complicating factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::055f63114eae62f2edf3156cedff666c
https://doi.org/10.1016/0197-2456(86)90121-2
https://doi.org/10.1016/0197-2456(86)90121-2
Publikováno v:
Clinical Research Practices and Drug Regulatory Affairs. 3:443-443
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3762886602bbf76f394e771ed587e41a
https://doi.org/10.3109/10601338509051076
https://doi.org/10.3109/10601338509051076